pharmacrisis
28,408 views
4 Discussing
Hot
Latest
🚨🚨 #TrumpTariffs 🚨#pharmacrisis 🚨🚨
🔴 BREAKING: Trump to Announce Tariffs on Pharmaceuticals Soon 💊⚠
📌 Key Updates:
💰 Tariff Details: A 25% tax on imported pharmaceuticals from countries like Canada, Mexico, and China.
📈 Impact on Drug Prices: Industry warns higher medication costs and potential drug shortages in the U.S. 🚨
🏭 Supply Chain Risks: 72% of U.S. pharmaceutical ingredients come from abroad—tariffs could disrupt imports and delay production.
🌍 Global Economic Concerns: Countries like Ireland (a major pharma exporter) fear job losses and inflation 📉.
🚢 Industry Response: European drugmakers are rushing shipments to the U.S. before tariffs hit.
#Tarif #TariffsImpact
$BTC
$SOL
$ETH
🔴 BREAKING: Trump to Announce Tariffs on Pharmaceuticals Soon 💊⚠
📌 Key Updates:
💰 Tariff Details: A 25% tax on imported pharmaceuticals from countries like Canada, Mexico, and China.
📈 Impact on Drug Prices: Industry warns higher medication costs and potential drug shortages in the U.S. 🚨
🏭 Supply Chain Risks: 72% of U.S. pharmaceutical ingredients come from abroad—tariffs could disrupt imports and delay production.
🌍 Global Economic Concerns: Countries like Ireland (a major pharma exporter) fear job losses and inflation 📉.
🚢 Industry Response: European drugmakers are rushing shipments to the U.S. before tariffs hit.
#Tarif #TariffsImpact
$BTC
$SOL
$ETH
🚨 #Trumptariffs 🚨#pharmacrisis 🚨
🔴 BREAKING: Trump to Announce Tariffs on Pharmaceuticals Soon 💊⚠
📌 Key Updates:
💰 Tariff Details: A 25% tax on imported pharmaceuticals from countries like Canada, Mexico, and China.
📈 Impact on Drug Prices: The industry warns higher medication costs and potential drug shortages in the U.S. 🚨
🏭 Supply Chain Risks: 72% of U.S. pharmaceutical ingredients come from abroad—tariffs could disrupt imports and delay production.
Global Economic Concerns: Countries like Ireland (a major pharma exporter) fear job losses and inflation 📉.
🚢 Industry Response: European drugmakers are rushing shipments to the U.S. before tariffs hit.
💭 What’s Next? Healthcare experts, economists, and global leaders are raising alarms 🚨 over possible trade wars and medical access issues
🔴 BREAKING: Trump to Announce Tariffs on Pharmaceuticals Soon 💊⚠
📌 Key Updates:
💰 Tariff Details: A 25% tax on imported pharmaceuticals from countries like Canada, Mexico, and China.
📈 Impact on Drug Prices: The industry warns higher medication costs and potential drug shortages in the U.S. 🚨
🏭 Supply Chain Risks: 72% of U.S. pharmaceutical ingredients come from abroad—tariffs could disrupt imports and delay production.
Global Economic Concerns: Countries like Ireland (a major pharma exporter) fear job losses and inflation 📉.
🚢 Industry Response: European drugmakers are rushing shipments to the U.S. before tariffs hit.
💭 What’s Next? Healthcare experts, economists, and global leaders are raising alarms 🚨 over possible trade wars and medical access issues
🚨🚨 #TrumpTariffs 🚨 #PharmaCrisis 🚨🚨
🔴 BREAKING: Trump Set to Announce Tariffs on Pharmaceuticals 💊⚠
📌 Key Updates:
💰 Tariff Details: A 25% tax on imported pharmaceuticals from Canada, Mexico, and China.
📈 Impact on Drug Prices: Experts warn of higher medication costs and potential drug shortages in the U.S. 🚨
🏭 Supply Chain Risks: 72% of U.S. pharmaceutical ingredients are imported—tariffs could disrupt supply chains and delay production.
🌍 Global Economic Concerns: Pharma-exporting countries like Ireland fear job losses and rising inflation 📉.
🚢 Industry Response: European drugmakers are rushing shipments to the U.S. before tariffs take effect.
💭 What’s Next? Healthcare experts, economists, and world leaders warn of trade wars and medical access issues 🚨.
🔗 Read more: CNN, Forbes, Reuters.
🔴 BREAKING: Trump Set to Announce Tariffs on Pharmaceuticals 💊⚠
📌 Key Updates:
💰 Tariff Details: A 25% tax on imported pharmaceuticals from Canada, Mexico, and China.
📈 Impact on Drug Prices: Experts warn of higher medication costs and potential drug shortages in the U.S. 🚨
🏭 Supply Chain Risks: 72% of U.S. pharmaceutical ingredients are imported—tariffs could disrupt supply chains and delay production.
🌍 Global Economic Concerns: Pharma-exporting countries like Ireland fear job losses and rising inflation 📉.
🚢 Industry Response: European drugmakers are rushing shipments to the U.S. before tariffs take effect.
💭 What’s Next? Healthcare experts, economists, and world leaders warn of trade wars and medical access issues 🚨.
🔗 Read more: CNN, Forbes, Reuters.
🚨🚨 #Trumptariffs 🚨#pharmacrisis 🚨🚨
🔴 BREAKING: Trump to Announce Tariffs on Pharmaceuticals Soon 💊⚠
📌 Key Updates:
💰 Tariff Details: A 25% tax on imported pharmaceuticals from countries like Canada, Mexico, and China.
📈 Impact on Drug Prices: Industry warns higher medication costs and potential drug shortages in the U.S. 🚨
🏭 Supply Chain Risks: 72% of U.S. pharmaceutical ingredients come from abroad—tariffs could disrupt imports and delay production.
🌍 Global Economic Concerns: Countries like Ireland (a major pharma exporter) fear job losses and inflation 📉.
🚢 Industry Response: European drugmakers are rushing shipments to the U.S. before tariffs hit.
💭 What’s Next? Healthcare experts, economists, and global leaders are raising alarms 🚨 over possible trade wars and medical access issues.
🔗 Read more: CNN, Forbes, Reuters.
🔴 BREAKING: Trump to Announce Tariffs on Pharmaceuticals Soon 💊⚠
📌 Key Updates:
💰 Tariff Details: A 25% tax on imported pharmaceuticals from countries like Canada, Mexico, and China.
📈 Impact on Drug Prices: Industry warns higher medication costs and potential drug shortages in the U.S. 🚨
🏭 Supply Chain Risks: 72% of U.S. pharmaceutical ingredients come from abroad—tariffs could disrupt imports and delay production.
🌍 Global Economic Concerns: Countries like Ireland (a major pharma exporter) fear job losses and inflation 📉.
🚢 Industry Response: European drugmakers are rushing shipments to the U.S. before tariffs hit.
💭 What’s Next? Healthcare experts, economists, and global leaders are raising alarms 🚨 over possible trade wars and medical access issues.
🔗 Read more: CNN, Forbes, Reuters.
Login to explore more contents